| Subject: | Boston Scientific Announces Worldwide Recall of Hemashield Vantage Peripheral Vascular Grafts June 27, 2005 |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Tue, 5 Jul 2005 - 10:00 am |
| Boston Scientific Corporation initiated a voluntary worldwide recall for all Hemashield VANTAGE Vascular Grafts, which are used in peripheral vascular procedures. No other Hemashield products are affected by this recall.
All Hemashield VANTAGE Vascular Grafts manufactured in the past two years are being recalled because of a potential for the device to fray or tear during suturing and the possibility that it could lead to postoperative complications.
The Company is aware of three reported... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
|
|
StayAlert!® Virtual Compliance Administrator™ keeps clients informed by email of any changes to Federal regulations, including Joint Commission (TJC, formerly JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG, and many more, and also provides downloadable tools to ensure compliance. StayAlert! is a premium product sold as an annual site-license subscription. With the site license, the client can sign up an unlimited number of users for the email alerts and access to the StayAlert! online regulatory library. The strength of StayAlert! rests in its ability to allow healthcare organizations to streamline their businesses using the Internet as a foundation architecture. StayAlert! provides cost containment and reduction through elimination of unnecessary overhead, and work caused by errors or poor access to information. |
|
